These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35179961)

  • 41. [Effects of Yisui Jiedu Recipe on JAK2-STAT5 signal transduction pathway in bone marrow hematopoietic cells from patients with myelodysplastic syndrome-refractory anemia].
    Tian SL; Zhou YM; Huang T; Xue ZZ; He W
    Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):185-9. PubMed ID: 18241656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What biologic factors predict for transformation to AML?
    Bejar R
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):341-345. PubMed ID: 30466744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.
    Shastri A; Choudhary G; Teixeira M; Gordon-Mitchell S; Ramachandra N; Bernard L; Bhattacharyya S; Lopez R; Pradhan K; Giricz O; Ravipati G; Wong LF; Cole S; Bhagat TD; Feld J; Dhar Y; Bartenstein M; Thiruthuvanathan VJ; Wickrema A; Ye BH; Frank DA; Pellagatti A; Boultwood J; Zhou T; Kim Y; MacLeod AR; Epling-Burnette PK; Ye M; McCoon P; Woessner R; Steidl U; Will B; Verma A
    J Clin Invest; 2018 Dec; 128(12):5479-5488. PubMed ID: 30252677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
    Schaefer EJ; Lindsley RC
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
    Miltiades P; Lamprianidou E; Vassilakopoulos TP; Papageorgiou SG; Galanopoulos AG; Kontos CK; Adamopoulos PG; Nakou E; Vakalopoulou S; Garypidou V; Papaioannou M; Hatjiharissi E; Papadaki HA; Spanoudakis E; Pappa V; Scorilas A; Tsatalas C; Kotsianidis I;
    Clin Cancer Res; 2016 Apr; 22(8):1958-68. PubMed ID: 26700206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of
    Jiang M; Chen Y; Deng L; Luo X; Wang L; Liu L
    DNA Cell Biol; 2019 May; 38(5):476-484. PubMed ID: 30835546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.
    Boehrer S; Adès L; Tajeddine N; Hofmann WK; Kriener S; Bug G; Ottmann OG; Ruthardt M; Galluzzi L; Fouassier C; Tailler M; Olaussen KA; Gardin C; Eclache V; de Botton S; Thepot S; Fenaux P; Kroemer G
    Oncogene; 2009 Jun; 28(22):2205-18. PubMed ID: 19398952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes.
    Picou F; Vignon C; Debeissat C; Lachot S; Kosmider O; Gallay N; Foucault A; Estienne MH; Ravalet N; Bene MC; Domenech J; Gyan E; Fontenay M; Herault O
    Blood Adv; 2019 Dec; 3(24):4271-4279. PubMed ID: 31869414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biologic characteristics of acute leukemia after myelodysplastic syndrome.
    Masuya M; Kita K; Shimizu N; Ohishi K; Katayama N; Sekine T; Otsuji A; Miwa H; Shirakawa S
    Blood; 1993 Jun; 81(12):3388-94. PubMed ID: 7685204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In Vitro Insights Into the Influence of Marrow Mesodermal/Mesenchymal Progenitor Cells on Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
    Liesveld J; Galipeau J
    Stem Cells; 2023 Sep; 41(9):823-836. PubMed ID: 37348128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
    Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
    Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
    Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
    Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
    Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the granulocyte colony-stimulating factor receptor gene structure using PCR-SSCP in myeloid leukemia and myelodysplastic syndrome.
    Shibata S; Asano Y; Yokoyama T; Shimoda K; Nakashima H; Okamura S; Niho Y
    Eur J Haematol; 1998 Mar; 60(3):197-201. PubMed ID: 9548419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.
    Xin H; Lu R; Lee H; Zhang W; Zhang C; Deng J; Liu Y; Shen S; Wagner KU; Forman S; Jove R; Yu H
    J Biol Chem; 2013 May; 288(19):13842-9. PubMed ID: 23548897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins.
    Bauer M; Vaxevanis C; Heimer N; Al-Ali HK; Jaekel N; Bachmann M; Wickenhauser C; Seliger B
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.
    Celik H; Koh WK; Kramer AC; Ostrander EL; Mallaney C; Fisher DAC; Xiang J; Wilson WC; Martens A; Kothari A; Fishberger G; Tycksen E; Karpova D; Duncavage EJ; Lee Y; Oh ST; Challen GA
    Cancer Cell; 2018 Nov; 34(5):741-756.e8. PubMed ID: 30423295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
    Jhanwar SC
    Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.
    Konuma T; Takahashi S; Uchida N; Kuwatsuka Y; Yamasaki S; Aoki J; Onishi Y; Aotsuka N; Ohashi K; Mori T; Masuko M; Nakamae H; Miyamura K; Kato K; Atsuta Y; Kato S; Asano S; Takami A; Miyazaki Y;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1632-40. PubMed ID: 25985920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.